Cystic Fibrosis Foundation vs Mammoth Biosciences
Cystic Fibrosis Foundation vs Mammoth Biosciences, compared side by side on 17 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Cystic Fibrosis Foundation is on 59/100 and Mammoth Biosciences on 63/100.
Where each one leads
Cystic Fibrosis Foundation
- domain rating: 80/100 against 53/100
- headcount: 1,183 against 165
Mammoth Biosciences
- our overall score: 63/100 against 59/100
- agent readiness: 35/100 against 25/100
- funding raised: $460M against $9.3M
At a glance
| Measure | Cystic Fibrosis Foundation | Mammoth Biosciences |
|---|---|---|
| What it is | A leading organization dedicated to curing and treating cystic fibrosis. | Biotechnology company leveraging ultracompact CRISPR systems for gene editing therapies and diagnostics. |
| Category | Biotechnology, Healthcare, Non-profit | Biotechnology, Drug Discovery, Genomics, CRISPR Technology |
| Sells toBusiness model | B2G | B2B |
| Offering | Services | Platform |
| Founded | 1955 | 2017 |
| Headquarters | Bethesda, USA | Brisbane, United States |
| Status | Active | Active |
Size, funding and growth
| Measure | Cystic Fibrosis Foundation | Mammoth Biosciences |
|---|---|---|
| Employees | 1,183 | 165 |
| Headcount growthLast 12 months | Not published | +5.8% |
| Total funding | $9.3M | $460M |
| Latest round | Series A | Funding Round |
| Valuation | Not published | $1.1B |
| LinkedIn followers | Not published | 57,986 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Cystic Fibrosis Foundation | Mammoth Biosciences |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 59/100 | 63/100 |
| Traction | 55/100 | 60/100 |
| Team | 30/100 | 70/100 |
| Search visibility | 2/100 | 35/100 |
| Quality | 78/100 | 68/100 |
| Agent readinessHow well an AI agent can read and act on the site | F (25/100) | F (35/100) |
| Domain ratingLink authority, 0-100 | 80/100 | 53/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Cystic Fibrosis Foundation | Mammoth Biosciences |
|---|---|---|
| CMS | Not detected | WordPress |
| Frameworks | Not detected | Jquery |
| Analytics | Not detected | Google Analytics 4 |
Cystic Fibrosis Foundation vs Mammoth Biosciences: common questions
Which is better, Cystic Fibrosis Foundation or Mammoth Biosciences?
On our 0-100 score Mammoth Biosciences rates higher (63/100 against 59/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 17 data points above: read the rows that match what you are buying for.
How do Cystic Fibrosis Foundation and Mammoth Biosciences compare on the numbers?
Cystic Fibrosis Foundation leads on domain rating (80/100 against 53/100), headcount (1,183 against 165). Mammoth Biosciences leads on our overall score (63/100 against 59/100), agent readiness (35/100 against 25/100), funding raised ($460M against $9.3M).
Read the full Cystic Fibrosis Foundation review and pricing or the Mammoth Biosciences review and pricing. You can also browse other Cystic Fibrosis Foundation alternatives we track.